Mydrilate en es it fr

Mydrilate Brand names, Mydrilate Analogs

Mydrilate Brand Names Mixture

  • No information avaliable

Mydrilate Chemical_Formula


Mydrilate RX_link

No information avaliable

Mydrilate fda sheet

Mydrilate msds (material safety sheet)

Mydrilate MSDS

Mydrilate Synthesis Reference

No information avaliable

Mydrilate Molecular Weight

291.385 g/mol

Mydrilate Melting Point

139 oC (hydrochloride salt)

Mydrilate H2O Solubility

No information avaliable

Mydrilate State


Mydrilate LogP


Mydrilate Dosage Forms

Ophthalmic solution (eye drops)

Mydrilate Indication

Used mainly to produce mydriasis and cycloplegia for diagnostic purposes.

Mydrilate Pharmacology

Cyclopentolate is an anti-muscarinic in the same class as atropine and scopolamine. Cyclopentolate blocks the receptors in the muscles of the eye (muscarinic receptors). These receptors are involved controlling the pupil size and the shape of the lens. Cyclopentolate thus induces relaxation of the sphincter of the iris and the ciliary muscles. When applied topically to the eyes, it causes a rapid, intense cycloplegic and mydriatic effect that is maximal in 15 to 60 minutes; recovery usually occurs within 24 hours. The cycloplegic and mydriatic effects are slower in onset and longer in duration in patients who have dark pigmented irises.

Mydrilate Absorption

Absorbed following ophthalmic administration.

Mydrilate side effects and Toxicity

Oral LD50 in the rat is 4000 mg/kg and 960 mg/kg in the mouse. Symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination and drowsiness.

Mydrilate Patient Information

No information avaliable

Mydrilate Organisms Affected

Humans and other mammals